跳至主要内容

Nanobody Preparation

 Medicilon provides camelid VHH antibody library construction services, including antigen preparation, immunization, construction of antibody library bacteria, nanobody selection, ELISA verification and other related experiments.

Nanobody Service Introduction
  • Nanobodies are superior to traditional antibodies in many ways. Based on the unique structure of VHH single-domain antibodies derived from camelid heavy chain antibodies, nanobodies combine the advantages of traditional antibodies and small molecule drugs. They almost perfectly overcome the shortcomings of long development cycles, low stability, and strict storage conditions of traditional antibodies. Nanobodies are gradually emerging as a new force in the development of therapeutic biopharmaceuticals and clinical diagnostic reagents.
    Compared to conventional antibodies, nanobodies have the following advantages:
    Small molecular weight, capable of penetrating the blood-brain barrier;High expression in prokaryotic or eukaryotic systems; strong specificity and high affinity;Strong specificity and high affinity;Weak immunogenicity in humans, etc.
M13 Phage Display Technology
  • Phage display technology is a method of expressing exogenous peptides or proteins by inserting their encoding genes into the appropriate location of the phage coat protein structural gene using genetic engineering techniques. The exogenous peptides or proteins can form fusion proteins on the coat protein of the phage during correct expression in the reading frame, and are presented on the surface of the phage along with progeny phages upon the reassembly of the phage.
    Then, using the target molecule, an appropriate panning method is used to wash away the non-specifically bound phage. The bound phages are then eluted with acid-base or competing molecules, and the neutralized phages are amplified by infecting Escherichia coli. After multiple rounds of enrichment, the proportion of phages that can specifically recognize the target molecule is gradually increased, eventually yielding peptides or proteins that recognize the target molecule.
Construction of Phage Library and Selection of Nanobodies
  • Medicilon provides unimmunized, full-age (24-36 months old) camels for antigen immunization. According to the standard immunization methods, each item is immunized with 4-6 injections. During the immunization period, ELISA titer determination services are provided to ensure that the anti-serum meets the qualified ELISA titer before blood collection and PBMC separation.
    Medicilon uses the pIII protein of M13 phage for surface display of VHH antibodies (nanobodies). Our scientists constructed a phagemid vector with double tags of HA and 6*His tag, and prepared a competent TG1 host strain with a transfection efficiency of 108. After 2-3 times of transfection and amplification, it can be used for high-quality VHH antibody display libraries with an effective library capacity greater than 108. After several rounds of nanobody library panning, at least 20 phage strains with high affinity can be obtained.
Comparison of Camel and Alpaca VHH Antibody Libraries
  • Comparison ItemCamel VHH Antibody LibraryAlpaca VHH Antibody Library
    Antigen toleranceHigh, multiple antigens can be mixed with high-dose immunizationHigher, multiple antigens can be mixed with medium immunization dose
    HCAb serum globulin ratio60%~80%20%~30%
    Neutralizing antibody titerHighHigh
    Blood collection volume200ml blood can be collected at one time80-100ml blood can be collected at one time
    Effective storage capacityHigh, immune library 108-109High, immune library 107-108
    Animal costLowerHigh
    Antigen requirement4-6mg, purity>85%4-5mg, purity>85%
Schematic diagram of nanobody preparation service process
  • Schematic diagram of nanobody preparation service process

    Image source: MA Lin-lin, et al. Construction and screening of phage display library for TIM-3 nanobody. Acta Pharmaceutica Sinica2018, 53 (3): 388-395.

Camelidae nanobody library preparation project process
  • StepContentCycleDelivery
    Step 1: Antigen preparationThe customer provides the antigen or Medicilon prepares the antigen3-4 weeksIf the customer provides the antigen, the quality standard: 1. >5mg; 2. SDS-PAGE >95%
    Step 2: Animal immunizationImmune unvaccinated camels
    5 ml unimmunized serum
    ELISA test serum titer
    10-12 weeksIf the animal dies due to antigen toxicity, a certain fee will be charged
    According to the ELISA results, client decides how to build the library
    Step 3: Antibody cDNA preparationPeripheral blood isolation of PBMC
    Extract total RNA and reverse transcribe into cDNA
    3-4 weeksProvide PBMC stored in Trizol
    Provide cDNA prepared by high-fidelity RT-PCR
    Step 4: Phage library constructionConstruction of phagemids
    Phage library construction
    VHH fragment insertion rate ≥75%
    Effective library capacity≥108CFU/mL
    Step 5: Phage library panningPhage display nanobody, panning, at least two rounds of panning
    ELISA verification, identification, screening and sequencing of positive clones (200 clones were sequenced)
    Sequencing of positive clones and analysis of sequencing results
    4-6 weeksAt least 20 sequences are guaranteed

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...

What is Toxicokinetics?

Toxicokinetics  is essentially the study of “how a substance gets into the body and what happens to it in the body”. Four processes are involved in toxicokinetics. The study of the kinetics (movement) of chemicals was originally conducted with pharmaceuticals and thus the term pharmacokinetics became commonly used. In addition, toxicology studies were initially conducted with drugs. However, the science of toxicology has evolved to include environmental and occupational chemicals as well as drugs. Toxicokinetics is thus the appropriate term for the study of the kinetics of all toxic substances. Frequently the terms  toxicokinetics ,  pharmacokinetics , or disposition may be found in the literature to have the same meaning. Disposition is often used in place of toxicokinetics to describe the time-course of movement of chemicals through the body (that is, how does the body dispose of a xenobiotic?). The disposition of a toxicant along with its’ biological reactivi...